LncRNA LINC00963 Downregulation Regulates Colorectal Cancer Tumorigenesis and Progression Via the MiR‑10b/FGF13 Axis

Overview

Journal Mol Med Rep

Specialty Molecular Biology

Date 2021 Jan 26

PMID 33495804

Citations 6

Authors

Yujin Wu

Longling Cong

Wenjian Chen

Xuechuan Wang

Fanghua Qiu

Affiliations

Soon will be listed here.

Abstract

Long non-coding RNAs (lncRNAs) serve a key role in different types of cancer, including colorectal cancer (CRC). The exact roles and mechanisms underlying lncRNA00963 [long intergenic non‑protein coding RNA 963 (LINC00963)] in CRC are not completely understood. The present study aimed to identify the effects and mechanisms underlying LINC00963 in CRC. Firstly, the LINC00963 expression was detected using reverse transcription‑quantitative PCR and the results demonstrated that LINC00963 expression levels were significantly increased in CRC tissues and cell lines compared with healthy tissues and HpoEpiC cells, respectively. Online database analysis indicated that high levels of LINC00963 were associated with low survival rates. The results of functional experiments, such as CCK‑8 assay, colony formation assay, wound healing assay and Transwell invasion assay, indicated that LINC00963 knockdown significantly inhibited CRC cell proliferation, colony formation, migration and invasion compared with the small interfering RNA (si)‑negative control (NC) group. Furthermore, the luciferase reporter indicated that LINC00963 competitively regulated microRNA (miR)‑10b by targeting fibroblast growth factor 13 (FGF13). Compared with si‑NC, LINC00963 knockdown decreased the expression levels of FGF13, vimentin and N‑cadherin, and increased the expression of E‑cadherin as detecting by western blotting. miR‑10b inhibitors partly attenuated si‑LINC00963‑induced inhibition of CRC cell proliferation, migration and invasion. Collectively, the results of the present study suggested a potential role of the LINC00963/miR-10b/FGF13 axis in the tumorigenesis and progression of CRC, indicating a novel lncRNA-based diagnostic or therapeutic target for CRC.

Citing Articles

Tumor-Derived Exosomal Circular RNA Pinin Induces FGF13 Expression to Promote Colorectal Cancer Progression through miR-1225-5p.

Liao X, Li T, Yang L, Li H, Li W, Liu Y Gut Liver. 2024; 18(6):1014-1025.

PMID: 38384181 PMC: 11565002. DOI: 10.5009/gnl230304.

Advances in targeting of miR‑10‑associated lncRNAs/circRNAs for the management of cancer (Review).

Gao S, Liu S, Wei W, Qi Y, Meng F Oncol Lett. 2023; 25(3):89.

PMID: 36817057 PMC: 9931999. DOI: 10.3892/ol.2023.13675.

lncRNA TRPM2-AS Promotes Colorectal Cancer Progression by Regulating miR-22-3p and FSTL1.

Gao Y, Liu B, Liu X, Gao Y, Shan J, Li Y J Oncol. 2022; 2022:1366511.

PMID: 36268275 PMC: 9578789. DOI: 10.1155/2022/1366511.

Upregulated Linc01836 in Serum Promisingly Serving as a Diagnostic and Prognostic Biomarker for Colorectal Cancer.

Shen L, Zong W, Feng W, Chen E, Ma S, Yuan J Front Pharmacol. 2022; 13:840391.

PMID: 35370745 PMC: 8975208. DOI: 10.3389/fphar.2022.840391.

Detection and analysis of long noncoding RNA expression profiles related to epithelial-mesenchymal transition in keloids.

Chen Z, Chu X, Xu J Biomed Eng Online. 2022; 21(1):2.

PMID: 35012558 PMC: 8751032. DOI: 10.1186/s12938-022-00976-x.

References

Kartha R, Subramanian S . Competing endogenous RNAs (ceRNAs): new entrants to the intricacies of gene regulation. Front Genet. 2014; 5:8. PMC: 3906566. DOI: 10.3389/fgene.2014.00008. View

Jiang N, Meng X, Mi H, Chi Y, Li S, Jin Z . Circulating lncRNA XLOC_009167 serves as a diagnostic biomarker to predict lung cancer. Clin Chim Acta. 2018; 486:26-33. DOI: 10.1016/j.cca.2018.07.026. View

Liu Y, Yang Y, Li L, Liu Y, Geng P, Li G . LncRNA SNHG1 enhances cell proliferation, migration, and invasion in cervical cancer. Biochem Cell Biol. 2017; 96(1):38-43. DOI: 10.1139/bcb-2017-0188. View

Wang L, Han S, Jin G, Zhou X, Li M, Ying X . Linc00963: a novel, long non-coding RNA involved in the transition of prostate cancer from androgen-dependence to androgen-independence. Int J Oncol. 2014; 44(6):2041-9. DOI: 10.3892/ijo.2014.2363. View

Wang L, Cho K, Li Y, Tao G, Xie Z, Guo B . Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Targets for Colorectal Cancer. Int J Mol Sci. 2019; 20(22). PMC: 6888455. DOI: 10.3390/ijms20225758. View

Bublik D, Bursac S, Sheffer M, Orsolic I, Shalit T, Tarcic O . Regulatory module involving FGF13, miR-504, and p53 regulates ribosomal biogenesis and supports cancer cell survival. Proc Natl Acad Sci U S A. 2016; 114(4):E496-E505. PMC: 5278483. DOI: 10.1073/pnas.1614876114. View

Rinn J, Chang H . Genome regulation by long noncoding RNAs. Annu Rev Biochem. 2012; 81:145-66. PMC: 3858397. DOI: 10.1146/annurev-biochem-051410-092902. View

Song J, Li W . MiR-10b suppresses the growth and metastasis of colorectal cancer cell by targeting FGF13. Eur Rev Med Pharmacol Sci. 2019; 23(2):576-587. DOI: 10.26355/eurrev_201901_16870. View

Marotta G, Muto T, Benincasa G, De Monaco A . Formyl peptide receptor 2 mediated chemotherapeutics drug resistance in colon cancer cells. Point of view from pharmacogenetics field. Eur Rev Med Pharmacol Sci. 2018; 22(5):1178-1179. DOI: 10.26355/eurrev_201803_14455. View

10.

Saliminejad K, Khorshid H, Soleymani Fard S, Ghaffari S . An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2018; 234(5):5451-5465. DOI: 10.1002/jcp.27486. View

11.

Hoek K, Rimm D, Williams K, Zhao H, Ariyan S, Lin A . Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res. 2004; 64(15):5270-82. DOI: 10.1158/0008-5472.CAN-04-0731. View

12.

Evans J, Feng F, Chinnaiyan A . The bright side of dark matter: lncRNAs in cancer. J Clin Invest. 2016; 126(8):2775-82. PMC: 4966302. DOI: 10.1172/JCI84421. View

13.

Di Cecilia S, Zhang F, Sancho A, Li S, Aguilo F, Sun Y . RBM5-AS1 Is Critical for Self-Renewal of Colon Cancer Stem-like Cells. Cancer Res. 2016; 76(19):5615-5627. PMC: 5050123. DOI: 10.1158/0008-5472.CAN-15-1824. View

14.

Wu C . Systemic Therapy for Colon Cancer. Surg Oncol Clin N Am. 2018; 27(2):235-242. DOI: 10.1016/j.soc.2017.11.001. View

15.

Schreuders E, Ruco A, Rabeneck L, Schoen R, Sung J, Young G . Colorectal cancer screening: a global overview of existing programmes. Gut. 2015; 64(10):1637-49. DOI: 10.1136/gutjnl-2014-309086. View

16.

Han Q, Xu L, Lin W, Yao X, Jiang M, Zhou R . Long noncoding RNA CRCMSL suppresses tumor invasive and metastasis in colorectal carcinoma through nucleocytoplasmic shuttling of HMGB2. Oncogene. 2018; 38(16):3019-3032. DOI: 10.1038/s41388-018-0614-4. View

17.

Zhang N, Zeng X, Sun C, Guo H, Wang T, Wei L . LncRNA LINC00963 Promotes Tumorigenesis and Radioresistance in Breast Cancer by Sponging miR-324-3p and Inducing ACK1 Expression. Mol Ther Nucleic Acids. 2019; 18:871-881. PMC: 6881674. DOI: 10.1016/j.omtn.2019.09.033. View

18.

Wu J, Tian X, An Q, Guan X, Hao C . LINC00963 promotes hepatocellular carcinoma progression by activating PI3K/AKT pathway. Eur Rev Med Pharmacol Sci. 2018; 22(6):1645-1652. DOI: 10.26355/eurrev_201803_14574. View

19.

Dey B, Mueller A, Dutta A . Long non-coding RNAs as emerging regulators of differentiation, development, and disease. Transcription. 2014; 5(4):e944014. PMC: 4581346. DOI: 10.4161/21541272.2014.944014. View

20.

Missiaglia E, Dalai I, Barbi S, Beghelli S, Falconi M, Della Peruta M . Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway. J Clin Oncol. 2009; 28(2):245-55. PMC: 4288616. DOI: 10.1200/JCO.2008.21.5988. View